Work

Phase I dose-finding and pharmacokinetic study of a combination of elisidepsin (E) and erlotinib (T) in patients (pts) with advanced solid tumors.

Year: 2012

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2012.30.15_suppl.3093

Authors: Sanjay Goel, Teresa Moran, Cinthya Coronado, Santiago Viteri Ramirez, Imran Chaudhary, Mohammad Haroon Ghalib, Umang Swami, Yijuan Hou, Enric Carcereny, Jose Alcantara, Jorge Luis Iglesias Dios, Bernardo De Miguel, Cristina Buges, Rafael Rosell

Institutions: Montefiore Medical Center, Montefiore Einstein Comprehensive Cancer Center, Institut Català d'Oncologia, Hospital Universitari Germans Trias i Pujol, PharmaMar (Spain), Hospital Universitario Dexeus

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2594998874

Cites:

Cited by: 3

Related to: 10